Downregulation of Ripk1 and Nsf mediated by CRISPR-CasRx ameliorates stroke volume and neurological deficits after ischemia stroke in mice
Xincheng Song(Peking University), Dantao Peng(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 4